Skip to main content

Table 1 Antimicrobial susceptibility test results of 1179 S.maltophilia clinical isolates

From: Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro

Antibiotics Sensitive Intermediate Resistant Non-susceptible rate
Levofloxacin (LVX) 1082 16 81 8.23%
Minocyline (MH) 1142 25 12 3.14%
Sulfamethoxazole (SXT) 1105 21 53 6.28%